Insiders · Profile

PANOFF MARC L

Chief Financial Officer at Travere Therapeutics. Filing since 15 Aug 2013. CIK 0001304340

Company
Date
Role
Action
Shares
Amount
Of holding
15 Aug 2013
Chief Financial Officer
Bought
1,100
$4.95K
0.9%
1 decision on file.